These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11258063)

  • 1. [Analysis of the prevention of post-ivermectin Loa loa encephalopathy by administration of initial low dose].
    Kamgno J; Gardon J; Boussinesq M
    Med Trop (Mars); 2000; 60(3):275-7. PubMed ID: 11258063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
    Ducorps M; Gardon-Wendel N; Ranque S; Ndong W; Boussinesq M; Gardon J; Schneider D; Chippaux JP
    Bull Soc Pathol Exot; 1995; 88(3):105-12. PubMed ID: 8555762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
    Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
    Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a 3-day regimen of albendazole (800 mg daily) on Loa loa microfilaraemia.
    Tsague-Dongmo L; Kamgno J; Pion SD; Moyou-Somo R; Boussinesq M
    Ann Trop Med Parasitol; 2002 Oct; 96(7):707-15. PubMed ID: 12537632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the progr,ammes of Community-Directed Treatment with Ivermectin carried out in Africa.
    Pion DS; Gardon J; Kamgno J; Gardon-Wendel N; Chippaux JP; Boussinesq M
    Parasitology; 2004 Nov; 129(Pt 5):613-26. PubMed ID: 15552406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg).
    Kamgno J; Pion SD; Tejiokem MC; Twum-Danso NA; Thylefors B; Boussinesq M
    Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):777-85. PubMed ID: 17531279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked decrease in Loa loa microfilaraemia six and twelve months after a single dose of ivermectin.
    Gardon J; Kamgno J; Folefack G; Gardon-Wendel N; Bouchité B; Boussinesq M
    Trans R Soc Trop Med Hyg; 1997; 91(5):593-4. PubMed ID: 9463678
    [No Abstract]   [Full Text] [Related]  

  • 8. Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study.
    Pion SD; Nana-Djeunga H; Niamsi-Emalio Y; Chesnais CB; Deléglise H; Mackenzie C; Stolk W; Fletcher DA; Klion AD; Nutman TB; Boussinesq M; Kamgno J
    Lancet Infect Dis; 2020 Jan; 20(1):102-109. PubMed ID: 31676244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis.
    Boussinesq M; Gardon J; Gardon-Wendel N; Kamgno J; Ngoumou P; Chippaux JP
    Am J Trop Med Hyg; 1998 Apr; 58(4):461-9. PubMed ID: 9574793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
    Kamgno J; Pion SD; Chesnais CB; Bakalar MH; D'Ambrosio MV; Mackenzie CD; Nana-Djeunga HC; Gounoue-Kamkumo R; Njitchouang GR; Nwane P; Tchatchueng-Mbouga JB; Wanji S; Stolk WA; Fletcher DA; Klion AD; Nutman TB; Boussinesq M
    N Engl J Med; 2017 Nov; 377(21):2044-2052. PubMed ID: 29116890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event.
    Bourguinat C; Kamgno J; Boussinesq M; Mackenzie CD; Prichard RK; Geary TG
    Am J Trop Med Hyg; 2010 Jul; 83(1):28-32. PubMed ID: 20595473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin.
    Esum M; Wanji S; Tendongfor N; Enyong P
    Trans R Soc Trop Med Hyg; 2001; 95(6):673-6. PubMed ID: 11816443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial.
    Turner JD; Tendongfor N; Esum M; Johnston KL; Langley RS; Ford L; Faragher B; Specht S; Mand S; Hoerauf A; Enyong P; Wanji S; Taylor MJ
    PLoS Negl Trop Dis; 2010 Apr; 4(4):e660. PubMed ID: 20405054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection.
    Boussinesq M; Gardon J
    Ann Trop Med Parasitol; 1997 Sep; 91(6):573-89. PubMed ID: 9425360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a single dose (600 mg) of albendazole on Loa loa microfilaraemia.
    Kamgno J; Boussinesq M
    Parasite; 2002 Mar; 9(1):59-63. PubMed ID: 11938697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance and efficacy of single high-dose ivermectin for the treatment of loiasis.
    Martin-Prevel Y; Cosnefroy JY; Tshipamba P; Ngari P; Chodakewitz JA; Pinder M
    Am J Trop Med Hyg; 1993 Feb; 48(2):186-92. PubMed ID: 8447521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon.
    Boussinesq M; Gardon J; Kamgno J; Pion SD; Gardon-Wendel N; Chippaux JP
    Ann Trop Med Parasitol; 2001 Jul; 95(5):495-507. PubMed ID: 11487371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case Report: Probable Case of Spontaneous Encephalopathy Due to Loiasis and Dramatic Reduction of
    Arrey-Agbor DB; Nana-Djeunga HC; Mogoung-Wafo AE; Mafo M; Danwe C; Kamgno J
    Am J Trop Med Hyg; 2018 Jul; 99(1):112-115. PubMed ID: 29741149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular findings after ivermectin treatment of patients with high Loa loa microfilaremia.
    Fobi G; Gardon J; Santiago M; Ngangue D; Gardon-Wendel N; Boussinesq M
    Ophthalmic Epidemiol; 2000 Mar; 7(1):27-39. PubMed ID: 10652169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections.
    Richard-Lenoble D; Kombila M; Rupp EA; Pappayliou ES; Gaxotte P; Nguiri C; Aziz MA
    Am J Trop Med Hyg; 1988 Nov; 39(5):480-3. PubMed ID: 3195695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.